{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Imaging of Novel Oncologic Treatments in Lung Cancer Part 2: Local Ablative Therapies ((Non-Physician Credit))

Activity Steps


The certificate for this activity is for NON-PHYSICIANS.

Method of Participation in the Learning Process/Evaluation Method

Successful completion of this activity includes reading the entire article and successfully completing the post-quiz and an evaluation form.

Getting the Most out of the Activity

As you prepare to participate in this activity, please reflect on your practice and your patients and identify clinical challenges you hope to have addressed.

While participating in the training, identify ways you can use newly acquired knowledge, strategies, and skills to enhance patient outcomes and your own professional development.

Learning Objectives

After completing this continuing education activity you will be able to:

  1. Assess the role of targeted ablative therapies in lung cancer, namely stereotactic body radiation therapy (SBRT) and percutaneous ablative therapy.
  2. Outline the patterns of response and recurrence with novel ablative therapies compared with conventional therapies.
  3. Identify imaging finding of thoracic-related adverse events associated with targeted ablative therapies.
Price: FREE


  • ACCME 1.5 CME
  • ABR 1.5 CME (SAM)

Lippincott Continuing Medical Education Institute, Inc. is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Lippincott Continuing Medical Education Institute, Inc. designates this enduring material for a maximum of 1.5 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This module meets the American Board of Radiology's (ABR) criteria for self-assessment toward the purpose of fulfilling requirements in the ABR Maintenance of Certification (MOC) program.

Test Code: JTIN0120B
Published: January 2020
Expires: 12/31/2021
Required Passing Score: 4/5 (80%)
Authors: Darragh Halpenny, MBBCh, BAO, Elisabeth O'Dwyer, MBBCh, BAO, Juan Camacho Vasquez, MD, Narek Shaverdian, MD, Jeffrey Girshman, MD, and Michelle S. Ginsberg, MD
Categories: Cancer , Pulmonary , Thoracic
Specialties: Oncology, Pulmonary, Radiology